| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A comprehensive company database analysis of biological assay variability
|
Kramer, Christian
|
|
2016
|
21 |
8 |
p. 1213-1221
9 p.
|
artikel
|
| 2 |
Advantages and challenges offered by biofunctional core–shell fiber systems for tissue engineering and drug delivery
|
Sperling, Laura E.
|
|
2016
|
21 |
8 |
p. 1243-1256
14 p.
|
artikel
|
| 3 |
An improved model for fragment-based lead generation at AstraZeneca
|
Fuller, Nathan
|
|
2016
|
21 |
8 |
p. 1272-1283
12 p.
|
artikel
|
| 4 |
Application areas of 3D bioprinting
|
Ozbolat, Ibrahim T.
|
|
2016
|
21 |
8 |
p. 1257-1271
15 p.
|
artikel
|
| 5 |
Biofunctionalized nanoparticles: an emerging drug delivery platform for various disease treatments
|
Bose, Rajendran J.C.
|
|
2016
|
21 |
8 |
p. 1303-1312
10 p.
|
artikel
|
| 6 |
Contents page 2
|
|
|
2016
|
21 |
8 |
p. ii-
1 p.
|
artikel
|
| 7 |
Contents page 1
|
|
|
2016
|
21 |
8 |
p. i-
1 p.
|
artikel
|
| 8 |
Descriptors and their selection methods in QSAR analysis: paradigm for drug design
|
Danishuddin,
|
|
2016
|
21 |
8 |
p. 1291-1302
12 p.
|
artikel
|
| 9 |
Development of cell therapy medicinal products by academic institutes
|
de Wilde, Sofieke
|
|
2016
|
21 |
8 |
p. 1206-1212
7 p.
|
artikel
|
| 10 |
Increasing experimental reproducibility, from antibodies to protein arrays
|
Ko Ferrigno, Paul
|
|
2016
|
21 |
8 |
p. 1197-1199
3 p.
|
artikel
|
| 11 |
Optimising B-cell depletion in autoimmune disease: is obinutuzumab the answer?
|
Reddy, Venkat
|
|
2016
|
21 |
8 |
p. 1330-1338
9 p.
|
artikel
|
| 12 |
Secondary pharmacology: screening and interpretation of off-target activities – focus on translation
|
Whitebread, Steven
|
|
2016
|
21 |
8 |
p. 1232-1242
11 p.
|
artikel
|
| 13 |
Self-assembly drug conjugates for anticancer treatment
|
Fumagalli, Gaia
|
|
2016
|
21 |
8 |
p. 1321-1329
9 p.
|
artikel
|
| 14 |
Targeting delivery in Parkinson's disease
|
Newland, Ben
|
|
2016
|
21 |
8 |
p. 1313-1320
8 p.
|
artikel
|
| 15 |
Targeting PRAS40 for multiple diseases
|
Chong, Zhao Zhong
|
|
2016
|
21 |
8 |
p. 1222-1231
10 p.
|
artikel
|
| 16 |
The common marmoset as an indispensable animal model for immunotherapy development in multiple sclerosis
|
Kap, Yolanda S.
|
|
2016
|
21 |
8 |
p. 1200-1205
6 p.
|
artikel
|
| 17 |
Treatment of insulin resistance: straight from the gut
|
Zhang, Xueli
|
|
2016
|
21 |
8 |
p. 1284-1290
7 p.
|
artikel
|
Tijdschrift beschrijving